US Court of Appeals Lifts Injunction Against Abbott's HCV Genotyping Technology | GenomeWeb
NEW YORK (GenomeWeb News) – The US Court of Appeals for the Federal Circuit yesterday lifted a year-old injunction on Abbott Laboratories’ hepatitis C virus genotyping technology stemming from a patent infringement suit brought against the firm by Innogenetics in 2005.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.